“We always say that infection prevention is everyone’s business, and the pandemic reflects that."

A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.

In December 2020, the federal government’s massive precision medicine research initiative, All of Us (AoU), made available to qualified researchers initial results from its ongoing COVID-19 Participant Experience (COPE) Survey, as well as physical activity and heart rate data collected from Fitbit devices worn by AoU participants.

David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture.

Country music icon Dolly Parton received her COVID-19 vaccination at Vanderbilt Health Tuesday from Naji Abumrad, MD, and urged everyone not to hesitate to get their vaccine when they become eligible to receive it.

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

The latest version of vumc2go — the workforce’s internal news mobile app — makes it easier for Vanderbilt University Medical Center employees to download the app, connect with virtual events around the health system and track their COVID-19 vaccine appointments.